Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States

Affiliations

¹ Pharmerit - an OPEN Health Company, Bethesda, MD, United States.
² Merck & Co. Inc., Kenilworth, NJ, United States.
³ Division of Women's Community and Population Health, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, NC, United States.

Published Erratum

Masoom Priyadarshini et al. Front Public Health. 2021.

. 2021 Jul 26:9:691634.

doi: 10.3389/fpubh.2021.691634. eCollection 2021.

¹ Pharmerit - an OPEN Health Company, Bethesda, MD, United States.
² Merck & Co. Inc., Kenilworth, NJ, United States.
³ Division of Women's Community and Population Health, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, NC, United States.

Abstract

[This corrects the article DOI: 10.3389/fpubh.2020.624092.].

Keywords: cervical cancer; human papillomavirus; mortality; oropharyngeal cancer; productivity loss.

Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.
Priyadarshini M, Prabhu VS, Snedecor SJ, Corman S, Kuter BJ, Nwankwo C, Chirovsky D, Myers E. Priyadarshini M, et al. Front Public Health. 2021 Feb 16;8:624092. doi: 10.3389/fpubh.2020.624092. eCollection 2020. Front Public Health. 2021. PMID: 33665180 Free PMC article.